129 related articles for article (PubMed ID: 38859866)
1. The small-molecule drug homoharringtonine targets HSF1 to suppress pancreatic cancer progression.
Li GH; Miao Y; Chen H; Xue MF; Wang JY; Zhang JW; Yi ZF; Sun ZL
Am J Cancer Res; 2024; 14(5):2072-2087. PubMed ID: 38859866
[TBL] [Abstract][Full Text] [Related]
2. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
Ishikawa C; Mori N
Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
[TBL] [Abstract][Full Text] [Related]
3. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1.
Dong B; Jaeger AM; Hughes PF; Loiselle DR; Hauck JS; Fu Y; Haystead TA; Huang J; Thiele DJ
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328331
[TBL] [Abstract][Full Text] [Related]
4. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
[TBL] [Abstract][Full Text] [Related]
5. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
6. HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
Huang M; Dong W; Xie R; Wu J; Su Q; Li W; Yao K; Chen Y; Zhou Q; Zhang Q; Li W; Cheng L; Peng S; Chen S; Huang J; Chen X; Lin T
Cancer Commun (Lond); 2022 May; 42(5):447-470. PubMed ID: 35434944
[TBL] [Abstract][Full Text] [Related]
7. Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels.
Li N; Wang T; Li Z; Ye X; Deng B; Zhuo S; Yao P; Yang M; Mei H; Chen X; Zhu T; Chen S; Wang H; Wang J; Le Y
Cancer Biol Med; 2019 May; 16(2):220-233. PubMed ID: 31516744
[TBL] [Abstract][Full Text] [Related]
8. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.
Yoon YJ; Kim JA; Shin KD; Shin DS; Han YM; Lee YJ; Lee JS; Kwon BM; Han DC
J Biol Chem; 2011 Jan; 286(3):1737-47. PubMed ID: 21078672
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.
Isermann T; Schneider KL; Wegwitz F; De Oliveira T; Conradi LC; Volk V; Feuerhake F; Papke B; Stintzing S; Mundt B; Kühnel F; Moll UM; Schulz-Heddergott R
bioRxiv; 2024 Feb; ():. PubMed ID: 38464125
[TBL] [Abstract][Full Text] [Related]
10. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine.
Howard TP; Oberlick EM; Rees MG; Arnoff TE; Pham MT; Brenan L; DoCarmo M; Hong AL; Kugener G; Chou HC; Drosos Y; Mathias KM; Ramos P; Seashore-Ludlow B; Giacomelli AO; Wang X; Freeman BB; Blankenship K; Hoffmann L; Tiv HL; Gokhale PC; Johannessen CM; Stewart EA; Schreiber SL; Hahn WC; Roberts CWM
Clin Cancer Res; 2020 Sep; 26(18):4995-5006. PubMed ID: 32631955
[TBL] [Abstract][Full Text] [Related]
11. Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor.
Millson SH; Piper PW
Oncotarget; 2014 Jul; 5(13):5054-64. PubMed ID: 24970820
[TBL] [Abstract][Full Text] [Related]
12. Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.
Chen Y; Chen J; Yu J; Yang G; Temple E; Harbinski F; Gao H; Wilson C; Pagliarini R; Zhou W
J Biol Chem; 2014 Jul; 289(27):18914-27. PubMed ID: 24831003
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of cancer cells by small molecules targeting heat shock stress response.
Zhang D; Zhang B
Biochem Biophys Res Commun; 2016 Sep; 478(4):1509-14. PubMed ID: 27553278
[TBL] [Abstract][Full Text] [Related]
14. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.
Kim JA; Kim Y; Kwon BM; Han DC
J Biol Chem; 2013 Oct; 288(40):28713-26. PubMed ID: 23983126
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition.
Pastorek M; Muller P; Coates PJ; Vojtesek B
PLoS One; 2018; 13(8):e0202758. PubMed ID: 30138434
[TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors of HSF1 functional activity by high-content target-based screening.
Au Q; Zhang Y; Barber JR; Ng SC; Zhang B
J Biomol Screen; 2009 Dec; 14(10):1165-75. PubMed ID: 19820069
[TBL] [Abstract][Full Text] [Related]
17. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
[TBL] [Abstract][Full Text] [Related]
18. Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective.
Workman P
Adv Exp Med Biol; 2020; 1243():163-179. PubMed ID: 32297218
[TBL] [Abstract][Full Text] [Related]
19. Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer.
Rossi A; Ciafrè S; Balsamo M; Pierimarchi P; Santoro MG
Cancer Res; 2006 Aug; 66(15):7678-85. PubMed ID: 16885369
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of HSF1 and DYRK2 impedes cancer progression.
Tandon V; Moreno R; Allmeroth K; Quinn J; Wiley SE; Nicely LG; Denzel MS; Edwards J; de la Vega L; Banerjee S
Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36622366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]